We enable longer and healthier living through detection and monitoring of serious disease

At Chembio, our mission is to be a leader in the development, manufacture and commercialization of diagnostic solutions. We are dedicated to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). As a global company, we are committed to innovation and the highest quality standards.

At the core of our commitment is our patented Next Generation DPP® (Dual Path Platform) technology. Our DPP® technology is a breakthrough in POC diagnostics, offering significant advantages over lateral-flow technologies including:

Significantly improved sensitivity

Multiplexing – multiple test results via a single blood sample (e.g., HIV-Syphilis Assay)

Application in a number of indications

Today our DPP® technology is the basis of multiple collaborations with healthcare innovators and leaders worldwide spanning infectious diseases such as HIV, Zika, Ebola, syphilis, malaria and febrile illness, as well as potential new uses in the diagnosis of a specific form of cancer and brain injury (concussion).

Chembio was founded in 1986 and is headquartered in Medford, US

Chembio has an office in Medford

Medford, US (HQ)

3661 Horseblock Road

Chembio's revenue was reported to be $6.3 m in Q1, 2017

USD

## Revenue (Q1, 2017) | 6.3 m |

## Gross profit (Q1, 2017) | 3.1 m |

## Gross profit margin (Q1, 2017), % | 49% |

## Net income (Q1, 2017) | (1.6 m) |

## EBIT (Q1, 2017) | (1.6 m) |

## Market capitalization (18-Aug-2017) | 75.6 m |

## Cash (31-Mar-2017) | 5.6 m |

Chembio's current market capitalization is $75.6 m.

- Source: SEC Filings

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 29.5 m | 27.6 m | 24.3 m | 17.9 m |

## Revenue growth, % | (6%) | (12%) | (26%) | |

## Cost of goods sold | 17.2 m | 16.8 m | 13.8 m | 9.4 m |

## Gross profit | 12.3 m | 10.8 m | 10.5 m | 8.5 m |

## Gross profit Margin, % | 42% | 39% | 43% | 47% |

## R&D expense | 8.4 m | |||

## General and administrative expense | 7.6 m | |||

## Operating expense total | 16 m | |||

## EBIT | 1 m | (1.6 m) | (3.6 m) | (7.6 m) |

## EBIT margin, % | 3% | (6%) | (15%) | (42%) |

## Interest expense | 335 | 836 | ||

## Interest income | 5.8 k | 5.8 k | 2.4 k | 25.5 k |

## Pre tax profit | 1 m | (1.6 m) | (3.6 m) | (7.5 m) |

## Income tax expense | 487 k | (412.9 k) | (1.2 m) | 5.8 m |

## Net Income | 530.8 k | (1.1 m) | (2.4 m) | (13.3 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 7.4 m | 7.3 m | 6.2 m | 6.7 m | 6.9 m | 6.6 m | 3.3 m | 3.7 m | 6.3 m |

## Cost of goods sold | 4.4 m | 4.7 m | 3.5 m | 3.7 m | 4 m | 3.4 m | 1.7 m | 1.8 m | 3.2 m |

## Gross profit | 3 m | 2.7 m | 2.7 m | 3 m | 2.9 m | 3.2 m | 1.6 m | 2 m | 3.1 m |

## Gross profit Margin, % | 40% | 36% | 43% | 45% | 42% | 48% | 48% | 52% | 49% |

## R&D expense | 1.3 m | 972.4 k | 1.6 m | 1.8 m | 1.6 m | 1.6 m | 2.4 m | 2.3 m | 2.2 m |

## General and administrative expense | 1.9 m | 1.9 m | 2 m | 2.2 m | 1.9 m | 2 m | 1.6 m | 1.8 m | 2.5 m |

## EBIT | (232.9 k) | (262.5 k) | (468.2 k) | (2.4 m) | (2.1 m) | (1.6 m) | |||

## EBIT margin, % | (3%) | (4%) | (7%) | (73%) | (57%) | (26%) | |||

## Interest income | 1.6 k | 1.1 k | 1.2 k | 316 | 353 | 2.6 k | 1.3 k | 5.9 k | 13.4 k |

## Pre tax profit | (237 k) | (261.3 k) | (465.6 k) | (2.4 m) | (2.1 m) | (1.6 m) | |||

## Net Income | (146 k) | (270.6 k) | (303.6 k) | (8.3 m) | (2.1 m) | (1.6 m) |

- Source: SEC Filings

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 9.7 m | 4.6 m | 5.4 m | 10.6 m |

## Accounts Receivable | 525.6 m | |||

## Inventories | 3.2 m | 3.6 m | 3.6 m | 3.3 m |

## Current Assets | 18.5 m | 17.7 m | 12.6 m | 18.1 m |

## PP&E | 2 m | 2.8 m | 2.4 m | 1.7 m |

## Total Assets | 24.5 m | 25 m | 20.8 m | 20.6 m |

## Accounts Payable | 3 m | |||

## Current Liabilities | 4.3 m | 5.3 m | 3.2 m | 3.4 m |

## Total Liabilities | 3.4 m | |||

## Additional Paid-in Capital | 46.9 m | 47.6 m | 47.9 m | 60.7 m |

## Retained Earnings | (26.8 m) | (27.9 m) | (30.3 m) | (43.7 m) |

## Total Equity | 20.2 m | 19.7 m | 17.7 m | 17.2 m |

## Financial Leverage | 1.2 x | 1.3 x | 1.2 x | 1.2 x |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Cash | 6.8 m | 3.7 m | 2.8 m | 1.6 m | 1.1 m | 2.7 m | 1.4 m | 12.2 m | 5.6 m |

## Inventories | 4.1 m | 4 m | 3.7 m | 3.8 m | 3 m | 3.4 m | 3.5 m | 3.4 m | 3.8 m |

## Current Assets | 17.5 m | 17 m | 16.2 m | 15.7 m | 15.2 m | 12 m | 10.4 m | 20.6 m | 15.9 m |

## PP&E | 2.1 m | 2.1 m | 3 m | 2.8 m | 2.6 m | 2.2 m | 2 m | 1.8 m | 1.9 m |

## Goodwill | 1.2 m | ||||||||

## Total Assets | 24.1 m | 23.9 m | 24.1 m | 23.5 m | 22.8 m | 20.2 m | 12.7 m | 22.7 m | 20.9 m |

## Accounts Payable | 3.8 m | 3.8 m | 4.4 m | 4.7 m | 4.4 m | 2.4 m | 2.7 m | 2.6 m | 3.4 m |

## Current Liabilities | 3.8 m | 3.8 m | 4.9 m | 4.9 m | 4.6 m | 2.8 m | |||

## Additional Paid-in Capital | 47.3 m | 47.4 m | 47.7 m | 47.8 m | 47.8 m | 47.9 m | 48 m | 60.6 m | 62.5 m |

## Retained Earnings | (27.2 m) | (27.4 m) | (28.6 m) | (29.2 m) | (29.7 m) | (30.6 m) | (39 m) | (41.1 m) | (45.3 m) |

## Total Equity | 20.3 m | 20.1 m | 19.2 m | 18.6 m | 18.2 m | 17.4 m | 9.2 m | 19.6 m | 17.4 m |

## Financial Leverage | 1.2 x | 1.2 x | 1.3 x | 1.3 x | 1.3 x | 1.2 x | 1.4 x | 1.2 x | 1.2 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | 530.8 k | (1.1 m) | (2.4 m) | (13.3 m) |

## Depreciation and Amortization | 607.8 k | 739.3 k | 1.4 m | 1.1 m |

## Accounts Receivable | 263.2 k | (3.8 m) | 5.9 m | (960.8 k) |

## Inventories | (700.7 k) | (449.6 k) | 60.3 k | 242.8 k |

## Cash From Operating Activities | 2.3 m | (3.8 m) | 1.8 m | (6.7 m) |

## Cash From Investing Activities | (885.6 k) | (1.5 m) | (1 m) | (668.7 k) |

## Cash From Financing Activities | 5.3 m | 237.2 k | 12.6 m |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (146 k) | (270.6 k) | (303.6 k) | (8.3 m) | (2.1 m) | (1.6 m) | |||

## Inventories | 4.1 m | 4 m | 3.7 m | 3.8 m | 3 m | 3.4 m | 3.5 m | 3.4 m | 3.8 m |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 48.3 k |

## Financial Leverage | 1.2 x |